JDD November 2024 Issue Highlights | Special Focus: Lasers, Light Sources, and Devices
LASERS The November Journal of Drugs in Dermatology Editor's Picks spotlight the dynamic intersection of Lasers, Light Sources, and Devices in dermatology, featuring a mix of insightful studies and discussions. This month’s selections include an intriguing national survey capturing over 190 dermatologists' perspectives on the role of AI chatbots in dermatology, examining the potential applica …
LASERS
Patient Buzz: Melanonychia Causes | The Expert Weighs In
MelanonychiaHealth recently posted an article on the causes of melanonychia. While a black line on a patient’s nail is a common presentation, melanonychia may have a harmless cause or it may be a sign of a more serious health condition. How should a dermatology clinician conduct a workup for melanonychia, and when is a biopsy necessary? For an expert’s take, I reached out to Molly Hinshaw, MD, profes …
Melanonychia
Friday Pop Quiz 11/8/2024
The patient developed this cutaneous adverse event 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication? A. Epidermal growth factor receptor (EGFR) inhibitor B. Tumor necrosis factor (TNF)-alpha inhibitor C. Smoothened inhibitor D. BRAF inhibitor E. Programmed cell death (PD)-1 inhibitor To find out the correct answer and …
Dr. Kwatra’s Insights on Emerging Advances in Chronic Itch
chronic itchAs dermatologists, we recognize that chronic itch is a complex and often debilitating condition that significantly impacts our patients' quality of life, affecting their physical health, mental well-being, and daily activities. Chronic itch can be especially challenging to diagnose and treat, particularly in patients with skin of color, who may experience unique clinical manifestations and complic …
chronic itch
Using Cosmeceuticals for Pigmentary Disorders | Expert Insights from Dr. Heather Woolery-Lloyd
CosmeceuticalsThe many alternatives to hydroquinone make this an exciting time for using cosmeceuticals to treat pigmentary disorders, according to Dr. Heather Woolery-Lloyd, director of the Skin of Color Division at the University of Miami Miller School of Medicine’s Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery. In an interview with Next Steps in Derm, in partnership with Pigmentary Diso …
Cosmeceuticals